Schedule 13D ownership disclosure

XILIO THERAPEUTICS INC

Security class unavailable · CUSIP: 98422T100

Event date: 2021-10-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-321303
Form type
SC 13D
Filer
RiverVest Venture Fund IV, L.P.
CIK
CIK 1725443
Filed
Nov 05, 2021
Reporting period
Oct 26, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub